[1] CHEN W,ZHENG R,BAADE P D,et al. Cancer statistics in China,2015[J]. CA Cancer J Clin,2016,66(2):115-132. [2] MORISE Z,KAWABE N,TOMISHIGE H,et al. Recent advances in the surgical treatment of hepatocellular carcinoma[J]. World J Gastroenterol,2014,20(39):14381-14392. [3] SUN Y H,XU Y H,XU J,et al. Role of TM4SF1 in regulating breast cancer cell migration and apoptosis through PI3KAKT mTOR pathway[J]. Int J Clin Exp Pathol,2015,8(8):9081-9088. [4] HUANG Y K,FAN X G,QIU F,et al. Genomics of hepatitis B virus-related hepatocellular carcinoma and adjacent noncancerous tissues with cDNA microarray[J]. Chin Med J (Engl),2011,124(13):2057-2064. [5] WANG L,YAO M,DONG Z,et al. Circulating specific biomarkers in diagnosis of hepatocellular carcinoma and its metastasis monitoring[J]. Tumor Biol,2014,35(1):9-20. [6] SEO D C,SUNG J M,CHO H J,et al. Gene expression profiling of cancer stem cell in human lung adenocarcinoma A549 cells[J]. Mol Cancer,2007,6:75. [7] 阳志军,杨光,蒋燕明. 血清中肿瘤相关抗原自身抗体谱与CA125联合检测在卵巢恶性肿瘤诊断及病情监测中的价值[J]. 中华妇产科杂志,2011,46(2):113-118. [8] HUANG Y K,FAN X G,QIU F. TM4SF1 promotes proliferation,invasion,and metastasis in human liver cancer cells[J]. Int J Mol Sci,2016,17(5):661. [9] SHIH S C,ZUKAUSKAS A,LI D,et al. The L6 protein TM4SF1 is critical for endothelial cell function and tumor angiogenesis[J]. Cancer Res,2009,69(8):3272-3277. [10] VISINTIN A,KNOWLTON K,TYMINSKI E,et al. novel anti-TM4SF1 antibody-drug conjugates with activity against tumor cells and tumor vasculature[J]. Mol Cancer Ther,2015,14(8):1868-1876. |